Brief: Conmed sees FY adjusted EPS of USD 3.3-3.5
26/04/2023 23:02
Apr 26 (Reuters) - Conmed Q1 net income USD 1.819 million. * Q1 sales USD 295.468 million * Q1 pretax profit USD 2.444 million * Q1 income from operations USD 12.699 million * Q1 EPS USD 0.06 * Outlook FY adjusted EPS USD 3.3-3.5 * Outlook FY revenue USD 1,205-1,250 million
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED